title: Rapidly developed neurosyphilis in a psoriasis patient under treatment with infliximab: a case report.
authors.affiliation: Department of Dermatology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo 060-8543, Japan. kkase@sapmed.ac.jp.
authors.forename: Kimi
authors.initials: K
authors.lastname: Kase
authors.forename: Yasue
authors.initials: Y
authors.lastname: Ishii-Osai
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Sumikawa
authors.forename: Akihiro
authors.initials: A
authors.lastname: Yoneta
authors.forename: Daisaku
authors.initials: D
authors.lastname: Himeno
authors.forename: Yohei
authors.initials: Y
authors.lastname: Kakutani
authors.forename: Toshiharu
authors.initials: T
authors.lastname: Yamashita
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D000069285:Infliximab / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D009494:Neurosyphilis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology* / Q000523:psychology; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology* / Q000523:psychology; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D012307:Risk Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab